Source: Annual Congress 2012 - PG5 Obstructive sleep apnoea syndrome
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
P. Levy (Grenoble, France). Consequences of OSA. Annual Congress 2012 - PG5 Obstructive sleep apnoea syndrome

Member's Comments

No comment yet.

Related content which might interest you: Pathophysiology of OSA Source: Annual Congress 2012 - PG5 Obstructive sleep apnoea syndrome Year: 2012 Metabolic consequences of OSA in children Source: Annual Congress 2009 - PG21 Morbidity and mortality of sleep-disordered breathing: jointly organised with ACCP Year: 2009 Consequences of hypoxia-reoxygenation fenomen in the patients with OSAS Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007 Impact of CPAP treatment on pro-BNP in obstructive sleep apnea syndrome Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing Year: 2015 Prevalence of obstructive sleep apnea syndrome and CPAP adherence in the elderly Chinese population Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults I: questionnaires, epidemiology and sleep studies Year: 2015 Determinants of subclinical atherosclerosis in patients with obstructive sleep apnoea Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults III: questionnaires, epidemiology and sleep studies Year: 2015 Role of CPAP treatment in elderly with moderate obstructive sleep apnea Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019 Obstructive sleep apnea syndrome (OSA) and hypercoagulability – What is the impact of sole OSA in the absence of comorbities? Source: Annual Congress 2013 –Sleep disordered breathing in special situations I Year: 2013 Patterns of CPAP usage in patients with minimally symptomatic OSA Source: International Congress 2015 – To treat or not to treat? Sleep-disordered breathing II Year: 2015 Late Breaking Abstract - Long-term noninvasive ventilation in obesity hypoventilation syndrome without severe obstructive sleep apnoea Source: Virtual Congress 2020 – ALERT: Ventilation and rehabilitation Year: 2020 Sleep apnoea and hypoventilation syndromes - cardiometabolic consequences Source: International Congress 2018 – PG7 Sleep-disordered breathing - diagnosis and therapy Year: 2018 Protective cardiovascular effect of sleep apnea severity in obesity hypoventilation syndrome Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels Year: 2016 Factors influencing efficacy of BiPAP therapy in severe obstructive sleep apnea Source: Annual Congress 2013 –Sleep disordered breathing in special situations III Year: 2013 Clinical predictors of obesity hypoventilation syndrome in morbidly obese subjects with obstructive sleep apnoea Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I Year: 2015 Predictors of long-term PAP-adherence in obstructive sleep apnea syndrome Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012 Predictors of titrating pressure using A-CPAP in obstructive sleep apnea Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I Year: 2015 Predictors of nocturnal hypertension in obstructive sleep apnea patients with metabolic syndrome Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013 Albuminuria in moderate and severe obstructive sleep apnoea (OSA) patients Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing Year: 2015 Obstructive sleep apnoea syndrome and a calculation of cardiovascular risk Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters Year: 2014